Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
Dr Aravind S
Eligibility
Inclusion criteria
Inclusion criteria: Patients started on a topical steroid for the first time from our department Patients already on topical steroid with or without features of topical steroid abuse
Exclusion criteria
Exclusion criteria: Patients unwilling to give consent Patients below 18 years of age Patients already treated with long term oral steroid or other immunosuppressants Patients planned for oral steroid treatment Patients having comorbidities that resemble or can cause changes similar to topical steroid side effects (e.g., polycystic ovaries/Cushingâ??s syndrome/thyroid disorders) Patients undergoing intralesional steroid injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enumerate and describe the clinical features in steroid applied skin of different duration Enumerate and describe the dermoscopic findings in steroid applied skin of different duration Compare between perilesional steroid applied skin and morphologically similar normal skin, clinically as well as dermoscopically in view of describing any steroid-induced early changesTimepoint: At baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Attempt at classifying clinical and dermoscopic changes of steroid use depending upon the potency of the agent used and duration of the application Study the progressive steroid-induced changes in steroid naïve patients who are started on topical steroids and who come for follow up at various intervalsTimepoint: At the end of study (Nov 2021) | — |
Countries
India
Contacts
Public ContactDr Aravind S
Kasturba Medical College
Outcome results
None listed